A specialist workspace, built in stages.
The following capabilities describe a proposed direction. They are not operational features or delivery commitments. Priorities will depend on user interviews, technical feasibility and appropriate data rights.
Healthcare equity market intelligence
Bring relevant clinical, regulatory and company events into a focused view for institutional healthcare equity workflows. Initial development would prioritise event context over expensive real-time market data.
Clinical trial monitoring
Explore source-linked trial records, milestones, endpoints and reported results. Expected completion dates would remain distinct from confirmed data-release dates.
Regulatory catalyst tracking
Explore calendars and timelines for relevant regulatory milestones, with jurisdiction, source and timing uncertainty visible.
Company and pharmaceutical pipeline intelligence
Connect companies with assets, indications, development stages and forthcoming milestones. The proposed scope includes biotechnology, pharmaceuticals and medical technology.
Company research and market analytics
Provide structured research context and, where feasible and appropriately licensed, analytical views. No market feed or commercial data licence is currently represented.
Institutional research workflows
Explore saved company views, watchlists, source links and event filters. The starting hypothesis is a concise catalyst workspace that can complement existing institutional tools.
Potential future trading integrations
Broker connectivity, licensed market feeds and execution integrations are longer-term possibilities requiring separate commercial, technical and regulatory assessment. No Bloomberg connection, broker integration or order execution is available.
Evidence before expansion
A first version should be tested for source accuracy, event relevance, date reliability and usefulness in real desk workflows. Subscription demand remains an unvalidated hypothesis.